Microbubble compositions and methods for oligonucleotide delivery
AssigneeAVI BioPharma, Inc.
InventorsThomas R. Porter, Patrick L. Iversen
Life of this patent
Estimating the term…
Abstract
The invention relates to a new and improved pharmaceutical composition and method for delivery of therapeutic agents. The methods and composition of the invention can be used with several therapeutic agents and can achieve site specific delivery of a therapeutic or diagnostic substance. This can allow for lower doses and for improved efficacy with drugs which traditionally reach targeted sites and can result in improved utility for agents such as oligonucleotides and polynucleotides which are plagued with problems with biodistribution.
Claims6
A composition for administration of an oligonucleotide, comprising:
- a plurality of filmogenic protein-encapsulated insoluble gas-filled microbubbles, wherein the insoluble gas is a perfluorocarbon or SF6;
- and an oligonucleotide, wherein the oligonucleotide is conjugated to said protein at a microbubble surface, which filmogenic protein is selected from the group consisting of albumin, human gamma globulin, human apotransferin, beta lactase and urease, which filmogenic protein is selected from the group consisting of albumin, human gamma globulin, human apotransferrin, beta lactase and urease.
A composition for administration of an oligonucleotide, wherein said composition is formed by incubating said oligonucleotide with an aqueous suspension of filmogenic protein-encapsulated SF6-or perfluorocarbon gas-filled microbubbles, which filmogenic protein is selected from the group consisting of albumin, human gamma globulin, human apotransferin, beta lactase and urease, which filmogenic protein is selected from the group consisting of albumin, human gamma globulin, human apotransferrin, beta lactase and urease.
Dependencies are inferred from the claim text.